Tech Start Up Fourier Intelligence Nabbed the “Shanghai Design 100+” for 2020-2021

Fourier Intelligence’s Lower Limb Exoskeleton, the ExoMotus™ M4, awarded the “Shanghai Design 100+” Award from the Shanghai Municipal Commission of Economy and Information Technology for 2022-2021

SHANGHAI, 29th May 2021 – Fourier Intelligence, a top rehabilitation industry leader, has won the “Shanghai Design 100+” award for their coveted lower limb exoskeleton, the ExoMotus™ M4.

This marks the second year for the “Shanghai Design 100+” awards ceremony hosted by the Shanghai Municipal Commission of Economy and Information Technology. The ceremony was held in the central plaza of Shanghai Shangsheng Xinsuo and was attended by many other companies, including those in design.

“Shanghai Design 100+” 2020-2021 Annual Event

To further promote the influence of Shanghai’s designers, the Shanghai Municipal Commission of Economy and Information Technology encourages innovation and creativity through the “Shanghai Design 100+” awards. In the recent 2020-2021 event, Fourier Intelligence was among the total of 1,541 design products, design events, and design cases collected.

The number of participations far exceeds the previous year. Design companies in the Yangtze River Delta, Beijing-Tianjin-Hebei, and Pearl River Delta actively partook for the award.

The awards ceremony was attended by 920 designers and design teams, covering over 30 industries, 100 review experts, with over 2.45 million public online votes and 15.35 million online clicks. 287 achievements were shortlisted, and sales of 25.91 billion yuan have been achieved, and total sales are expected to be 370.18 billion yuan. The “Shanghai Design 100+” awards were conferred after a thorough evaluation from a mix of industrial votes, key expert votes, and public voting.

Some Participants of the “Shanghai Design 100+” Awards

In this annual event, the ExoMotus™ M4 gait and body weight support system launched by Fourier Intelligence won the “Shanghai Design 100+” in 2020-2021. The exoskeleton is by far the first and only exoskeleton in the market with its own body weight supporting system.

Fourier Intelligence’s ExoMotus™ M4

The ExoMotus™ M4 lower limb rehabilitation robot adopts an integrated ergonomic design, is user-friendly, and can achieve gait functional training and multiple mode evaluations. The gait mechanical leg can provide the user with precise sensory input in the early stage of rehabilitation through repetitive walking and inhibit the formation of an abnormal gait pattern or learned non-use. Early gait training on the ground enhances plantar activation and biofeedback. Moreover, dynamic balance and symmetrical weight-bearing assessments can be performed before and after training, which provides a quantitative reference for measuring the outcome and progress of gait training with this futuristic assistive technology.

In addition to having multiple training modes and adjustable parameters, having the additional balance assessment and training modules are the three main characteristics of this lower limb rehabilitation robot that is designed to empower gait training. Through this feature, users can have personalised rehabilitation training.

The ExoMotus™ M4 will be launched into the Chinese market at the Shanghai GReAT 2021 annual summit at the end of July. The launch of this product into the international market is expected to be in early 2022.

Fourier Intelligence is recognised globally for its innovative and intelligent solutions that are based on independent research and development of core rehabilitation robot technology, providing medical institutions and patients with the world’s leading comprehensive advanced rehabilitation solutions. At present, the company has strategic partnerships with nearly 20 top universities and research institutes around the world to jointly develop progressive rehabilitation technologies and promote the application of rehabilitation robotics at the international level. Some of these partner institutions include the Shirley Ryan Ability Lab in Chicago, KITE Research Institute at the Toronto Rehabilitation Institute – University Health Network, ETH Zürich in Switzerland, National Healthcare Group in Singapore, and the University of Melbourne. Fourier Intelligence has over 1,000 installations in hospitals and institutions with a global presence in more than 50 countries and regions around the world.

For investor and media inquiries, please contact:

Sarah LIM (Senior Manager)
Fourier Intelligence
Phone: +65-6911-6651
Email: sarah.lim@fftai.com

0
kite-research-02

The KITE Research Institute at the Toronto Rehabilitation Institute – University Health Network and Fourier Intelligence announces Global Partnership

The KITE Research Institute at the Toronto Rehabilitation Institute – University Health Network and Fourier Intelligence have entered a global partnership to jointly develop a new world-class Rehabilitation Robotics Centre, based on Fourier’s next-gen RehabHub™ Concept, to further promote rehabilitation technology research and education.

Canada and Singapore – December 18, 2020 – The KITE Research Institute at the Toronto Rehabilitation Institute – University Health Network and Fourier Intelligence have formed an important global partnership by signing a Memorandum of Understanding (MOU). The two parties are pleased to announce they have entered a global partnership to expand KITE’s robotics research and education capabilities including establishment of a new world-class Rehab Robotics Centre with Fourier’s next-gen RehabHub™ and support from its network of researchers. A virtual signing event took place on Dec. 16.

Fourier’s next generation RehabHub™ Robotics and central patient management system.

The research at UHN will be conducted by KITE, the No. 1 ranked Rehab Research Facility in the world, and one of the principal research enterprises at Canada’s top research hospital network, UHN.

The announcement of this partnership is timely, given the impact of the COVID-19 crisis and society’s changing attitudes on the adoption of home-based rehabilitation technologies and telerehabilitation. The KITE-Fourier partnership brings together clinicians, researchers, and engineers in technology development to further propel the field of rehabilitation robotics/technologies and help support users through successful healthcare technology integrations.

Virtual MOU signing event between KITE and Fourier Intelligence (FI).
From top left: Mr Zen Koh (Co-Founder, Group Deputy CEO), Dr Milos Popovic (Director of the KITE Research Institute), Prof. Denny Oetomo (Co-Director University of Melbourne & Fourier Intelligence Robotics Lab)
From bottom left: Sarah Lim (Clinical Application Specialist, FI), Taya Hamilton (Clinical Application Consultant, FI), Sophia Li (Partnerships & Strategic Project Manager, KITE)

The MOU was co-signed by Dr Milos R. Popovic, Director of the KITE Research Institute, a pioneer in the field of bioengineering and assistive technologies and Zen Koh, Fourier Intelligence’s Co-Founder, Group Deputy CEO

“Zen and I have been acquainted for many years, and it is great to finally come together in a collaboration to realize what we have both been discussing for the past few years,” said Popovic, who is also a professor with the Institute of Biomedical Engineering at the University of Toronto . “Fourier is a great partner and this agreement will help us achieve KITE’s vision of developing a new world-class Rehab Robotics Centre. We are currently in the process of raising $12 million to get this Rehab Robotics Centre up and running.”

Dr Milos R. Popovic, Director of the KITE Research Institute.

“We are excited about this partnership. KITE, under the leadership of Milos, is considered one of the top global research facilities in the field of rehabilitation,” said Zen Koh, Fourier Intelligence’s Co-Founder, Group Deputy CEO. “Working together, we can consolidate our resources and jointly design and develop next-generation technologies for our clinicians and patients.”

Mr Zen Koh, Co-Founder, Group Deputy CEO, Fourier Intelligence.

The MOU coverage focuses on the field of, among others, robotics rehabilitation research, the formation of a joint lab with Fourier Intelligence’s multitude of institutional research labs and a regional education centre. Professor Denny Oetomo, who is leading the University of Melbourne & Fourier Intelligence Robotics Lab, was also present during the virtual signing ceremony. “We are thrilled to be able to work with KITE as they have well-integrated engineering and clinical testing,” added Oetomo.

To further strengthen the partnership, KITE will also join Fourier’s Global Rehabilitation and Assistive Technology Network (GReAT) Network, to optimize resource sharing and promote translational research of rehabilitation technology into clinical practice.

Fourier Intelligence’s RehabHub™

About University Health Network Toronto Rehabilitation Institute
Toronto Rehabilitation Institute is the largest rehabilitation hospital in Canada, and a member of the University Health Network. The research arm of the Toronto Rehabilitation Institute, KITE, is a world leader in complex rehabilitation science and is dedicated to improving the lives of people living with the effects of disability, illness, and ageing. KITE is one of the principal research enterprises at the University Health Network (UHN), Canada’s top research hospital with more than $350 million in total annual research expenditures.

About Fourier Intelligence
Fourier Intelligence is a technology-driven company, infusing creativity into the development of exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists, and patients, Fourier Intelligence aims to excel in developing and redefining rehabilitation robotics solutions with inter-connectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.

About Global Rehabilitation & Assistive Technology (GReAT) Network
GReAT Network is a network of clinical researchers formed under the coordination of Fourier Intelligence. The objective of the network is to optimise resource sharing in neurorehabilitation research, to advance known-best-care by optimising existing technologies in neurorehabilitation, as well as promoting innovative discoveries to be translated into clinical practice with due efficiency and circumspection.

For investor and media inquiries, please contact:
Zen Koh (Group Deputy CEO/Chief Strategy Officer)
Fourier Intelligence
Phone: +65-9338-2328
Email: zen.koh@fftai.com

UHN Media contact
Jarrett Churchill
Senior Advisor, Public Affairs and Communications
KITE | University Health Network
Jarrett.churchill@uhn.ca

0
fftai-post-01

Fourier Intelligence Released The LineMotus™ L1

On November 27-29, 2020, the 4th Chinese Association of Rehabilitation Medicine Annual Conference and International Rehabilitation Equipment Expo was held at the Beijing National Convention Center. Fourier Intelligence participated in the exhibition and released a new product, LineMotus™ L1 which is an intelligent linear motion training robot to empower the health care institutions in the elementary level.

LineMotus™ L1 inherits the design concept of “Less is more”. It simplifies the tedious upper limb rehabilitation exercises yet achieves point-to-point repetitive linear motion. The device is designed to be light and portable, easy to install, and suitable for a variety of rehabilitation methods.

Thanks to LineMotus™’s streamlined and compact structural design, users can adjust to a variety of training positions to achieve their rehabilitation goals. Users can also combine multiple devices to achieve complex exercise training such as shoulder joint adduction and abduction, elbow joint flexion and extension, and pushing-pulling motion.

With gamification training methods, multi-sensory interactive feedback can be achieved. With the immersive and interactive experience, users can have visual-audio feedback. The built-in mechanics of the interactive games are very much suitable for elderlies in the community health centre to train their muscle strength, control, and reaction.

With the Fourier Intelligence’s advanced device interconnection technology, multiple devices can be interconnected and interacted in real time. This can be implemented to both single and double upper limb training or group training, which gives LineMotus™ L1 its uniqueness when it comes to rehabilitation training.

Adhering to the fine tradition of Fourier intelligent rehabilitation robots, LineMotus™ L1 uses a new independently developed motion control card and high-performance motor to fully upgrade the core force feedback algorithm to achieve precise force control. The built-in high-precision sensor ensures that the whole training process is quantifiable.

It supports a full set of training modes such as active, passive, assistive, and resistance. It also provides personalised programs for various training such as motion control, muscle strength, and cognition, which covers the needs of the entire rehabilitation period.

Alex Gu Jie, CEO of Fourier Intelligence, mentioned that in the entire Fourier Intelligence RehabHub™ concept, LineMotus™ L1 is an entry-level linear motion training robotic device. The adoption of robotics at all level speeds up the coverage of intelligent rehabilitation system and promotes the abundancy of the industry hence bringing more intelligent technology into daily life. This allows more elderly people to enjoy intelligent rehabilitation services.

0
alex-gu-fourier

Fourier Intelligence Raises 100 Million RMB in Series C Financing Round

The company has completed a new round of funding to accelerate investment in research and development, sales and support.

Shanghai, Oct 23, 2020 – Fourier Intelligence announced it had completed its Series C financing round led by Vision Plus Capital, a leading venture capital fund focusing in digital healthcare and deep tech. Qianhai FOF, one of Fourier Intelligence’s current shareholder, co-invested in this round as well. This new round of funds will be mainly invested to further expand Fourier Intelligence’s already impressive product line, to enhance its fully integrated intelligent rehabilitation robotic system, known as the Fourier Intelligence RehabHubTM Concept.

The intelligent rehabilitation has been possible since the advent of the digital and intelligence era. Artificial Intelligence (AI) is the developing trend of the rehabilitation field while the viability of Fourier’s business model has been verified,” says Fourier Intelligence’s Founder, Group CEO and Executive Chairman Alex Gu. “Our investors fuel momentum into the company, which will further iterate and replicate the products to enter a high-growth period. We aim to form an industry-driven platform to achieve the strategic vision of Robotics for All.

Fourier Intelligence’s Founder, Group CEO and Executive Chairman, Alex Gu

As if the central kitchen that enables the restaurant industry to realise chain operations across the country and even globally, the standardisation of clinical rehabilitation protocols will also support the development of rehabilitation departments that deliver positive clinical outcomes consistently. Our target is to enable 50-100 thousand rehabilitation facilities globally through our RehabHubTM Concept, and eventually provide quality rehabilitation services to millions of elderly, paediatric, and neurological patients,” he claimed.

Headquartered in Shanghai and with offices in Singapore, Malaysia, Guangzhou and Zhuhai, Fourier Intelligence is an innovative global technology company dedicated to researching, manufacturing, and marketing of rehabilitation robotics and comprehensive intelligent solutions.

Founded in 2015, the company has teamed up with experienced researchers, engineers, and medical specialists to develop the complete rehabilitation system to serve hospitals, communities and patients.

We are excited about this collaboration with Fourier Intelligence, and we are confident that this investment will serve as the catalyst that will further fuel the already excellent growth trajectory Fourier Intelligence has been experiencing for the past two years. With its sterling track record in developing innovative, clinically applicable fully-integrated rehabilitation solutions as well as delivering proven rehabilitation medical services to create a complete rehabilitation ecosystem,” says Tian Min, partner of Vision Plus Capital.

She adds that “Rehabilitation is an important and vastly underrated industry segment with huge market potential. We are fully convinced that Fourier Intelligence is well-positioned to lead this trending industry globally, with its proven technology solution system (RehabHubTM), which consists of robotics, AI, big data, cloud-based patient management systems, and clinical service delivery model.

Fourier Intelligence has achieved encouraging growth and positive developments over the past years. More than 1,000 hospitals and research institutes have successfully installed technology solutions developed by Fourier Intelligence, across 30 countries worldwide. To ensure continuous technological innovation, Fourier Intelligence has established several joint research labs. Such as the Shirley Ryan AbilityLab based in Chicago, the ETH Sensory Lab based in Zürich and the Advanced Robotic Lab based in the University of Melbourne. Such strong global research networks are rare within our industry and is key towards our success.” says Fourier Intelligence Co-Founder, Group Deputy CEO, and Chief Strategy Officer, Zen Koh.

Fourier Intelligence Co-Founder, Group Deputy CEO, and Chief Strategy Officer, Zen Koh

Recent studies indicate that rehabilitation resources are incredibly scarce and unevenly distributed across China. The shortage of rehabilitation therapists are known to be as high as 300,000, and there is a severe lack of rehabilitation service capacity. Current practices are human-intensive and lack efficiency. It is estimated, just China alone, the anticipated market size for rehabilitation and its related industry exceed 100 billion RMB.

To address this significant shortfall, Fourier Intelligence launches the RehabHub™ Concept, aiming to improve the adoption of rehabilitation robotics and technologies in rehabilitation facilities. The RehabHub™ Concept will improve efficiency and efficacy and transform the conventional rehabilitation approach.

Fourier Intelligence’s RehabHub™ Concept

About Fourier Intelligence

Fourier Intelligence is a technology-driven company, infusing creativity into the development of exoskeleton and rehabilitation robotics since 2015. Together with researchers, therapists and patients, we aim to excel in developing and redefining rehabilitation robotics solutions with interconnectable intelligent robotics technology by elevating user experience with an intuitive, easy-to-use system to enhance the lives of both patients and therapists.

For investor and media inquiries, please contact:

Mr Zen Koh (Co-Founder / Deputy CEO / Chief Strategy Officer)
Fourier Intelligence
Phone: +65-9338-2328
Email: zen.koh@fftai.com

0
news-5

Chinese Startup Reinvent The Exoskeleton

For the 85 million disabled in China, obtaining a set of rehab exoskeletons is a far-off dream. The futuristic product, which promises greater flexibility and independence, can cost as much as half a million U.S. dollars. Considering that the average disposal income per capita in 2018 was RMB28,228 (US$4,155) in China, one would need to save 120 years of income to afford the equipment.

No wonder a slew of startups have attempted to create cheaper products to tap into this potentially massive and lucrative market. One of them is Fourier Intelligence, a Shanghai-based company backed by Chinese investors including IDG Capital and Shenzhen Qianhai Fund of Funds. But the path toward helping the disabled walk is full of daunting challenges.

“The real hurdle for us is that exoskeleton is not being widely used,” said Zen Koh, managing director of Fourier Intelligence, during a phone interview with China Money Network in January. “The main reason is the technological constraint: None of the known 165 companies, laboratories, and research institutions working on exoskeletons can build a product that can be worn on a daily basis for hours. Imagine you buy a several-hundred-thousand-worth device, but you still need to walk around with crutches, then what is the purpose?”

This creates a vicious circle, in which low usage and high price keep most consumers watching on the sidelines. It in turn leads to the inability to scale. What Fourier Intelligence wants to do is to make products at the price level of around US$20,000, eventually lower it to just a few thousand, making it affordable to all disabled.

At the same time, Fourier Intelligence, drawing its name from the French mathematician Joseph Fourier, is tweaking its products to suit the real needs of users. Its next-generation rehab exoskeleton product “Fourier X2” is designed to assist lower limb rehab for stroke patients and other victims of mobility impairment. The new product, being only one third as expensive as standard exoskeletons in the market, is equipped with a self-developed active motion control system. The system includes four power units and six multi-dimensional mechanical sensors installed near thighs, shanks and soles to read and react to users’ movement intentions. In comparison, most products in the market are based on predetermined programs of the exoskeletons to guide users’ movements.

Fourier Intelligence introduced its next-generation rehab exoskeleton product “Fourier X2” on January 21 to assist lower limb rehab for stroke patients and other victims of mobility impairment.

Zen Koh started serving as deputy CEO of Fourier Intelligence since June 2018. Prior to his current position, Koh was the managing director for Hocoma and the Assistant Chief Executive (ACE) for the Singapore National Co-operative Federation (SNCF), which is one of the apex bodies of cooperatives in Singapore.

Below is an edited version of the interview.

Q: How is the development of the exoskeleton market in China now?

A: I think the Chinese market is huge for exoskeleton because Chinese people are very receptive to new technologies. However, the race in the Chinese exoskeleton market hasn’t even started. I think we are at the exploratory phase.

I hate to say that I think a lot of companies are playing the role of a follower. They study what has been done around the world and try to make it better, cheaper and faster. In my observation, I feel that a lot of people do not know what exoskeleton products they are building and who/why they are building for.

This is dangerous. It’s a bit like reinventing the wheels. We are using the same resources – limited resources, and patience of consumers – to do the same thing again and again. It’s not surprising to me that the exoskeleton market is losing money.

And not just Chinese companies, many international companies build their products based on the latest and most “sexy” technologies available. Then they try to find or justify the needs for the patients. Look at the most successful exoskeleton companies in the world, like California-based Ekso Bionics, their share prices have been dropping for three years or five years till now.

Q: How should the Chinese exoskeleton industry innovate?

A: At this stage, exoskeleton developers, which are also generally known as robotic companies, will have to conduct research and development based on their experience in the market to meet the real needs of target customers. Our suggestion is to have a good understanding of the field. Then understanding our strength and using it to develop solutions for that field.

Fourier believes in identifying the purpose of the technologies to be developed. We work closely with clinicians and patients to understand users’ real needs.

Q: There are a lot of exoskeleton products in the market, which are usually priced at between US$70,000 to US$200,000. Is this price range suitable for consumers in China?

A: You must look at this question from two different angles. First, the price is high for sure. But if exoskeleton can help a person stand up and walk again, it is not expensive. The real challenge for us is that exoskeleton is not being widely used, due to technological constraint, price, and usability.

The main reason is the technological constraint: None of the known 165 companies, laboratories, and research institutions working on exoskeletons can build a product that can be used daily for long hours. Only a few are able to build safe exoskeleton products to perform independent movements. Yet balance is still a problem, meaning users still have to use crutches to be able to walk independently. Imagine you buy a several-hundred-thousand-worth device, but you still need to walk around with crutches, what is the purpose? The price is considered expensive because it cannot fully serve the needs of patients.

Consider it from a different angle: If the adoption of exoskeleton increases, the price will come down because of the economy of scale. We believe the price will eventually reduce to maybe US$55,000 or US$20,000, or even just a few thousand.

But if the economy of scale is not there, and there’s only a small quantity of usage, the price will not drop. So, it is like a vicious cycle, which together lead to low adoption rate. I think, in at least five to ten years, we will have a decent exoskeleton product that can serve the purpose of helping people work independently.

Q: What is your outlook for the industry?

A: In the past, foreign companies priced the device at around half a million U.S. dollars. In the future, I believe every single hospital, clinic, even small private clinic, and home-based therapist will be able to afford some forms of robotic devices to help them perform rehab and physical training tasks to achieve better results.

For Fourier, we hope to build our open platform, attracting an increasing number of clinicians, researchers, engineers, and even hobbyists to adopt our core technologies to develop more meaningful applications. We believe exoskeleton products eventually will become mainstream in three to five years. It is like air conditioners, washing machines, and smartphones, you will feel significantly inconvenient if you are deprived of it.

We hope to have intelligent machines that can interact with each other, send user data to the cloud and provide recommendations of solutions based on AI technology. They will become a great tool to help day-to-day tasks.

Q: Fourier Intelligence introduced a new product named “Fourier X2” in late January. What is special in the technologies adopted by it?

A: The new Fourier X2 is lighter, with better materials to make it more wearable. The application can be used in research, education, different augmentation application purposes, and industrial use.

Currently, the exoskeleton products in the Chinese market are passive, meaning users can only move in ways predetermined by programs of the exoskeleton equipment. The Fourier X2 has four senses in its self-developed active motion control system. We can understand the patients’ intention of movements to allow our machines to improve performances.

Q: The active motion control module applies enhanced algorithms to better handle the adjustment of users’ movement in real-time. Do you want to use artificial intelligence (AI) technology in the future?

A: Yes. They can be part of the machine learning after we have more data in the future. But as of now, the algorithms are used to optimize the controls including motion control and PID (proportional–integral–derivative) control.

Q: Will Fourier Intelligence develop other kinds of exoskeleton products in the future, like those in the Iron Man, which are used to augment human being’s physical strength?

A: Fourier focuses on the rehab and medical field. That’s why we are not venturing into robotics for other applications.

Q: Fourier raised a RMB30 million (US$4.44 million) series B round of financing in early 2018. How was the fundraising process?

A: It was smooth. We’re working on a new round of financing from three potential investors, hopefully to announce the completion of the new round latest by March or earliest by February. It is challenging during the current time as the expectation from investors is definitely higher.

1
news-2

Fourier Intelligence Showcases At Wcpt 2019 Expands Global Influence

Shanghai, May 15, 2019 – From May 10th to 13th, WCPT 2019 Congress was held in Geneva, Switzerland. Rehabilitation, as the core topic featuring on this year’s program, is also the focus of Fourier Intelligence. At a joint booth with the German and US partners, Fourier Intelligence represents its innovative products and promotes distinctive rehabilitation concepts. By participating in this grand gathering, Fourier Intelligence aims to strengthen its leadership in the rehabilitation market and also explore further development in the future of the healthcare industry.

The WCPT is the world’s largest and most influential congress in physical therapy and creates an international communication platform with over 4,000 physiotherapists, researchers, research institutions and rehabilitation companies. Fourier Intelligence is showcasing both Fourier M2 upper extremity rehabilitation robotics and Fourier X2 lower extremity rehabilitation robotics. The Fourier M2 simulates the therapist’s hand through haptic feedback sensors and provides a variety of training modes to meet different training goals at every stage of rehabilitation. The Fourier X2 provides intensive gait training for patients with hemiplegia, paraplegia, and spinal cord injury and to eventually walk independently. During WCPT, therapists show great interest in the Fourier’s technologies for upper and lower extremity rehabilitation and responded with great feedback.

Fourier Intelligence Team with the German partner and the US partner

Fourier Intelligence focuses on robotic technologies to assist in rehabilitation training and seeks to develop advanced robotic technologies for meaningful clinical application.

The therapist tries Fourier M2 Upper-Extremity Rehabilitation Robotics

The WCPT provides a communication stage to exchange views about the rehabilitation topics. “Now is the time to establish strong strategic cooperation to create win-win with our partners. We are in good progress in establishing a solid foothold in the German and Swiss market.” Fourier Intelligence Chief Strategy Officer (CSO), Zen Koh points out. “With our participation at WCPT, we will intensify our cooperation with global partners and customers. We will further expand our European market so that we can serve more people through widening access to our rehabilitation products.”

By being part of the WCPT, Fourier Intelligence is not only presenting its products but also come together with strategic partners to jointly promote the development of the physical therapy industry using advanced robotic technology.

1
20190402135139_50440

Fourier Intelligence To Field A Team Of Exoskeleton ‘Athletes’ For Cybathlon 2020

Shanghai, March 29, 2019 – Fourier Intelligence and University of Melbourne today announce to deepen their collaboration and join forces in a sports team, Advanced Lower Extremity eXoskeleton (A.L.E.X.) to attend Cybathlon competition in Zurich, 2020. This partnership focuses on representing the advances of Fourier X2 modular exoskeleton robotics and demonstrating its functionality in achieving typical tasks of daily life within the contest to other competitors.

Cybathlon is a championship for individuals with disabilities using advanced robotic assistive devices. A group of respective expertise from Fourier Intelligence and the University of Melbourne and their volunteer athletes, called pilots, team up for attending the Cybathlon 2020.

Pilots are those suffering from spinal cord injuries while their action commands from brains cannot pass through the damaged spinal nerves.

How, then, can researchers offer hope to assist these pilots in walking again and improving life self-care ability? The answer comes from the technology of lower extremity exoskeleton.

By applying Fourier X2 Intelligent Rehabilitation Robotics, this wearable device can read and react to users’ movement intentions and as a result, keep users mobile and independent. Furthermore, the team deploys the new, enhanced algorithm to adjust the users’ gait in real-time based on multi-dimensional mechanical sensors.

The highlight of Fourier X2 Robotics is the optimised user-centred handling. Interactive response by sensing the users’ intentions and needs instead of predetermine actions differentiates Fourier X2 apart from any other product in this field.

“Fourier X2 increases the torque output and breaks through the boundary of single training mode,” says Alex Gu, chief executive of Fourier Intelligence. “X2 is much more comfortable and user-friendly.” This could give the team a competitive advantage in Cybathlon race.

Altogether, the Cybathlon comprises six sporting disciplines and team A.L.E.X will be competing in the Powered Exoskeleton Race. During the competition, the pilots are challenged with a series of basic tasks including sitting down on a sofa and standing up, walking a slalom course and titled surfaces, walking up and down a steep ramp, opening a door and walking through it, walking over stepping stones. As the competition progresses, the challenges get more difficult for the pilots, for example completing tasks such as waking up and down stairs. The pilot with the best overall time wins.

Confirmed participating teams of Powered Exoskeleton Race

Team A.L.E.X will face various opponents from 10 countries during the race. Cybathlon is providing a valuable opportunity for industry and academia to compare and contrast a diverse range of assistive technologies under one roof, which has not been done on this scale before. It is motivating and rewarding to raise social awareness of assistive technology and disability, which eventually will encourage the translation of new technology.

As Zen Koh, Chief Strategy Officer of Fourier Intelligence said: “We notice that there is still a long way to promote exoskeleton robotics to be safer and more wearable. However, participating Cybathlon could provide us with a platform to represent our technologies and converge the goals between researchers and end-users. Meanwhile, we could widen the horizon to share and learn from others to lead to advances in the field.”

Team A.L.E.X puts massive efforts to prepare for the Cybathlon and looks forward to achieving great success at the race.

Fourier Intelligence is an innovative global technology company focusing on the developing, manufacturing and marketing of rehabilitation robotics and exoskeleton, based in Singapore and Shanghai. We strive to develop evidence-based top quality medical technologies that are accessible and affordable for all (hospitals, community-based rehab clinics, etc.).

For investor and media inquiries, please contact:
Mr. Zen Koh (MD & CSO)
Fourier Intelligence
Phone: +65 9338 2328 / +86 152 2114 9590
Email: zen.koh@fftai.com

1